1 Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 2014, 60:715-735.
2 American Association for the Study of Liver Diseases, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol, 2014, 61:642-659.
3 Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35: 716-721.
4 Butterworth RF, Norenberg MD, Felipo V, et al. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int, 2009, 29: 783-788.
5 段志军,张春乐. 大鼠肝性脑病模型的研究进展. 世界华人消化杂志, 2010, 18: 3204-3209.
6 Zimmermann C, Ferenci P, Pifl C, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology, 1989, 9: 594-601.
7 Farjam M, Dehdab P, Abbassnia F, et al. Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J, 2012, 14:164-170.
8 Gomides LF, Marques PE, Faleiros BE, et al. Murine model to study brain, behavior and immunity during hepatic encephalopathy. World J Hepatol, 2014, 6: 243-250.
9 Rama Rao KV, Verkman AS, Curtis KM, et al. Aquaporin-4 deletion in mice reduces encephalopathy and brain edema in experimental acute liver failure. Neurobiol Dis, 2014, 63:222-228.
10 逄菲,胡瑾华. 肝性脑病的动物模型及分子生物学机制研究进展. 国际消化病杂志,2014, 34: 84-86.
11 Chang HM, Liao YW, Chiang CH, et al. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc. Int J Mol Sci, 2012, 13: 3598-3617.
12 刘赴平,师玲玲. 四氯化碳造成急性肝损伤大鼠模型的实验研究. 中国输血杂志, 2012, 25: 446-448.
13 Traber PG, Dal Canto M, Ganger DR, et al. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology, 1987, 7: 1272-1277.
14 Zhou P, Xia J, Guo G, et al. A Macaca mulatta model of fulminant hepatic failure. World J Gastroenterol, 2012, 18: 435-444.
15 McMillin M, Frampton G, Thompson M, et al. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation, 2014, 11:121.
16 Baine AM, Hori T, Chen F, et al. Fulminant liver failure models with subsequent encephalopathy in the mouse. Hepatobiliary Pancreat Dis Int, 2011,10:611-619.
17 Shaik IH, Miah MK, Bickel U, et al. Effects of short-term portacaval anastomosis on the peripheral and brain disposition of the blood-brain barrier permeability marker sodium fluorescein in rats. Brain Res, 2013, 1531:84-93.
18 Yang X, Bosoi CR, Jiang W, et al. Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress. Metab Brain Dis, 2010, 25:11-15.
19 Klarik Z, Toth E, Kiss F, et al. A modified microsurgical model for end-to-side selective portacaval shunt in the rat. Intraoperative microcirculatory investigations. Acta Cir Bras, 2013, 28:625-631.
20 Méndez M, Méndez-López M, López L, et al. Acetylcholinesterase activity in an experimental rat model of Type C hepatic encephalopathy. Acta Histochem, 2011, 113: 358-362.
21 Kawai H, Ishibashi T, Kudo N, et al. Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis. J Toxicol Sci, 2012, 37:1165-1175.
22 Leke R, Oliveira DL, Forgiarini LF, et al. Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. Metab Brain Dis, 2012, 28: 187-192.
23 Leke R, Silveira TR, Escobar TD, et al. Expression of Glutamate Decarboxylase (GAD) mRNA in the brain of bile duct ligated rats serving as a model of hepatic encephalopathy. Neurochem Res, 2014, 39: 605-611.
24 Chen JR, Wang BN, Tseng GF, et al. Morphological changes of cortical pyramidal neurons in hepatic encephalopathy. BMC Neurosci, 2014, 15:15.
25 Jover R, Rodrigo R, Felipo V, et al. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology, 2006, 43:1257-1266.
26 Miquel M, Bartoli R, Odena G, et al. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema. Liver Int, 2010, 30:979-987.
27 贾林,张美华,苏常青,等. 硫代乙酰氨致大鼠轻微型肝性脑病模型的建立. 世界华人消化杂志, 2004, 12:1207-1208.
28 Singh S, Trigun SK. Low grade cirrhosis induces cognitive impairment and motor dysfunction in rats: could be a model for minimal hepatic encephalopathy. Neurosci Lett, 2014, 559:136-140.
29 Ding S, Huang W, Ye Y, et al. Elevated intracranial dopamine impairs the glutamate-nitric oxide-cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy. Mol Med Rep, 2014, 10: 1215-1224.
30 Bustamante J, Lores-Arnaiz S, Tallis S, et al. Mitochondrial dysfunction as a mediator of hippocampal apoptosis in a model of hepatic encephalopathy. Mol Cell Biochem, 2011, 354:231-240.
31 Leke R, de Oliveira DL, Mussulini BH, et al. Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats. PLoS One, 2012, 7:e36322. |
